UK markets open in 3 hours 51 minutes

NuCana plc (NCNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5500-0.0300 (-1.90%)
At close: 03:59PM EST
1.5800 +0.03 (+1.94%)
After hours: 07:40PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.5800
Open1.5700
Bid1.5200 x 4000
Ask1.5700 x 1000
Day's range1.5150 - 1.6100
52-week range0.5170 - 3.3200
Volume61,816
Avg. volume98,220
Market cap80.904M
Beta (5Y monthly)0.94
PE ratio (TTM)N/A
EPS (TTM)-0.9200
Earnings date25 Apr 2023 - 01 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.72
  • Globe Newswire

    NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

    EDINBURGH, United Kingdom, Jan. 23, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), (“NuCana” or the “Company”), announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) and the matter is

  • Globe Newswire

    NuCana Announces Receipt of NASDAQ Notice

    EDINBURGH, United Kingdom, Jan. 06, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that it received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated January 3, 2023, indicating that, based upon a closing bid price of less than $1.00 per share for the Company’s American Depositary Shares (“ADSs”) for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5450(a)(1). The Notification Letter h

  • Globe Newswire

    NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference

    EDINBURGH, United Kingdom, Jan. 03, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced today that management will host one-on-one meetings during the 41st Annual J.P. Morgan Healthcare Conference, January 9 – 12, 2023 in San Francisco. About NuCanaNuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleo